2017
DOI: 10.1016/j.ijcard.2016.11.201
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of soluble urokinase plasminogen activator receptor (suPAR) as an inflammatory biomarker in obese children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…The mean suPAR level in our cohorts was often several-fold higher than levels measured in children with normal weight or obesity, and it was comparable with or higher than in adults who will develop kidney disease. Also, suPAR levels tended to decrease with patient age.…”
Section: Discussionmentioning
confidence: 97%
“…The mean suPAR level in our cohorts was often several-fold higher than levels measured in children with normal weight or obesity, and it was comparable with or higher than in adults who will develop kidney disease. Also, suPAR levels tended to decrease with patient age.…”
Section: Discussionmentioning
confidence: 97%
“…1 ) concentration was in the expected range in the Healthy Control group. 4 , 29 Serum suPAR was not related to either chronic pain alone or obesity alone. However, there was a significant, classic interaction between pain and obesity on suPAR ( P = 0.046) reflected in a significant increase in serum suPAR in the Chronic Pain & Obese group compared to the other 3 groups ( P values shown in Fig.…”
Section: Resultsmentioning
confidence: 88%
“…The 2 studies of which we are aware that measured serum suPAR in adolescents with obesity alone have been conflicting. 4 , 29 More importantly, we are unaware of systematic studies of suPAR in conditions of chronic pain in any age group.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Inflammation is a major contributor to many diseases, and the biological determination of inflammation is of significant benefit in determining the prognosis of the disease. In recent years, YKL-40 and suPAR have been extensively used as inflammatory biomarkers [14,15].…”
Section: Introductionmentioning
confidence: 99%